Questions of novelty in medical use patents
When a substance with a diagnostic or therapeutic effect per se has been available in the prior art, it will become more important to effectively protect the medical use of the substance, particularly in a jurisdiction (such as China) where diagnostic or therapeutic methods are not patent-eligible.
